HomeNDC Lookup › 85992-0002-01
ONIADBA Fungal Nail Treatment Swabs TOLNAFTATE,UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid, 23 mL — NDC 85992-0002-01 package photo

ONIADBA Fungal Nail Treatment Swabs TOLNAFTATE,UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid, 23 mL

by Shenzhen Boyimei Technology Co., Ltd. · 100 BAG in 1 BOX (85992-002-01) / .23 mL in 1 BAG
NDC 85992-0002-01
🏷️ FDA NDC (as labeled) 85992-002-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 85992-002-01
Product NDC 85992-002
11-digit billing NDC 85992000201
RxCUI 2691548
UNII 06KB629TKV, K3D86KJ24N
Application # M005
SPL Set ID 3baa99ab-6d22-8d7d-e063-6294a90af3e8
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-08-06
Route TOPICAL
Dosage form LIQUID
Substance TOLNAFTATE; UNDECYLENIC ACID
Why two NDCs? The FDA registers this code as 85992-002-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 85992-0002-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerShenzhen Boyimei Technology Co., Ltd.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code85992
First marketedAug 2025
Product typeHuman Otc Drug
Portfolio7 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is a topical liquid treatment applied directly to affected nails using swabs. It contains tolnaftate and undecylenic acid, both of which are commonly used in over-the-counter antifungal products for fungal nail infections. This product is marketed as an OTC monograph drug, meaning it follows FDA's established rules for this category of antifungal treatments rather than undergoing individual product approval.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bldaxn Fungus Nail Pen .01 g/mL; .25 g/mL 76986-0026-01 Guangdong 4 bottles FDA listed
RDVHDLW Extra Strength NAIL REPAIR PEN .25 g/mL; .01 g/mL 83766-0001-01 Shenzhen 5 bottles FDA listed
DRAWZONE Toenail Fungus Treatment Pen 25 g/100mL; 1 g/100mL 83766-0107-01 Shenzhen 6 bottles FDA listed
ERWCNMIE Toenail Fungus Treatment Pen 1 g/100mL; 25 g/100mL 83766-0108-01 Shenzhen 3 bottles FDA listed
Nailtific Daytime Treatment Antifungal Pen Refill 1.5 g/6mL; .06 g/6mL 84167-0012-27 Guangzhou 1 bottle FDA listed
APUREE Pro Nailtific Maximum Strength Dual-Action Antifungal Pen 25 g/1; 1 g 84167-0364-02 Guangzhou 2 bottles FDA listed
APUREE Nailtific Extra-Max Strength Daytime Antigungal 1 g/1; 25 g 84167-0423-01 Guangzhou 1 vial FDA listed
APUREE Nailtific Extra-Max Strength Antigungal .25 g/1; .01 g 84167-0662-23 Guangzhou 5 bottles FDA listed
Toenail Fungus Treatment Extra Strength Pen 1 g/100mL; 25 g/100mL 85038-0001-01 Lianjiang 3 bottles FDA listed
TOENAIL FUNGUS TREATMENT Liquid 25 g/100mL; 1 g/100mL 85038-0002-01 Lianjiang 1 bottle FDA listed
Yamangu Fungal Nail Repair Pen 25 g/100mL; 1 g/100mL 85248-0196-01 Jiangxi 6 tubes FDA listed
Htrcsw Fungal Nail Renewal 25 g/100mL; 1 g/100mL 85248-0217-01 Jiangxi 3 tubes FDA listed
cmojsk TOENAIL FUNGUS PEN 1 g/100mL; 25 g/100mL 85248-0220-01 Jiangxi 4 tubes FDA listed
Fitcube NAIL REPAIR PEN 25 g/100mL; 1 g/100mL 85248-0230-01 Jiangxi 4 tubes FDA listed
TAGOQHIA Extra Strength NAIL REPAIR PEN 25 g/100mL; 1 g/100mL 85304-0031-01 Guangzhou 3 bottles FDA listed
Extra Strength Nail Fungus Treatment 1 g/100mL; 25 g/100mL 85966-0001-01 GUANGZHOU 30 ml FDA listed
Nail Fungus Treatment Pen 25 g/100mL; 1 g/100mL 85966-0005-01 GUANGZHOU 3 bottles FDA listed
Extra Strength Toenaiil Renewal Pen .01 g/mL; .25 g/mL 85966-0010-01 GUANGZHOU 5 ml FDA listed
EXTRA STRENGTH TOENAIIL RENEWAL Solution .25 g/mL; .01 g/mL 85966-0011-01 GUANGZHOU 1 bottle FDA listed
Extra Strength Toenail Renewal Pen .25 g/mL; .01 g/mL 85966-0012-01 GUANGZHOU 5 ml FDA listed
Extra Strength Toenail Renewal Solution .25 g/mL; .01 g/mL 85966-0013-01 GUANGZHOU 30 ml FDA listed
SSPROTIP X Extra Strength Toenail Renewal Solution .01 g/mL; .25 g/mL 85966-0017-01 GUANGZHOU 1 bottle FDA listed
ONIADBA Fungal Nail Treatment Swabs 1 g/100mL; 25 g/100mLthis 85992-0002-01 Shenzhen 23 ml FDA listed
WCTNGO Fungal Nail Treatment Swabs 1 g/100mL; 25 g/100mL 85992-0003-01 Shenzhen 23 ml FDA listed
ONIADBA Nail Fungus Treatment Pen 1 g/100mL; 25 g/100mL 85992-0004-01 Shenzhen 4 tubes FDA listed
Putrizen 1 g/4g; .04 g/4g 87724-5118-01 Guangzhou 5 applicators FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Aug 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
85992-0002-01 You're viewing this 100 BAG in 1 BOX (85992-002-01) / .23 mL in 1 BAG 2025-08-06 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 85992-002-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 85992-0002-01, written without dashes as 85992000201. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 85992-0002-01, the first segment (85992) is the labeler code FDA assigned to Shenzhen Boyimei Technology Co., Ltd.; the middle segment (0002) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Shenzhen Boyimei Technology Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Shenzhen Boyimei Technology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 23 words

Antifungal treatment for fingernails, toenails, and surrounding skin.Effective against fungal nails, athlete's foot, tinea manuum,and ringworm caused by fungi.Addresses nail fungus,discoloration.thickening,splitting, and crumbling.

⏱️ Dosage and Administration 107 words

Wash the affected area and dry thoroughly. Snap off the tip swabbelow red line. Liquid will begin flowing into the other end of swab tip.

The swab applicator allows for easy application to the skin around the nail. Apply a thin layer of liquid over the affected area twice daily(morning and night) or as directed by a doctor. Supervise children inthe use of product.

Pay attention to the spaces between the toeswear well-fitingventilated shoes, and change shoes and socks at least once dailye Allow the nail and surrounding areas to dry. Use only oneswab per treatment. Please continue to use this product for at least 4 weeks.

⚠️ Warnings 23 words

Keep away from fire and flames Keep out of reach of children For external use on nails and the immediately adjacent skin only

🧪 Active Ingredient 5 words

Tolnaftate 1% Undecylenic Acid 25%

🧪 Inactive Ingredients 4 words

ALCOHOL,DIMETHICONE, C12-15 ALKYLLACTATE.ETHYLHEXYLGLYCERIN.TOCOPHEROL,EDETATE DISODIUM.PHENOXYETHANOL,WATER

🎯 Purpose 1 words

Anti-fungal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.